As part of important efforts to address the epidemic of opioid misuse and abuse, the FDA launched an innovation challenge on May 31, 2018, to spur the development of medical devices, including diagnostic tests and digital health technologies (mobile medical applications) to help combat the opioid crisis and achieve the goal of preventing and treating opioid use disorder.
